酒精性肝病发病机制研究进展*

doi:10.3969/j.issn.1672-5069.2014.01.002

Abstract

Wang Hongyan, Li Xin, Xu Youqing. Progress in the pathogenesis of alcoholic liver disease[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2014, 17(1): 5-8.

[1] Rehm JC,Mathers S,Popov A,et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet, 2009, 373（9682）：2223-2233.
[2] 任燚,肖庆贵,邬吉伟,等. 酒精性肝病临床流调现状. 现代保健·医学创新研究,2008,5（35）：55-56.
[3] Gao B,Bataller R. Alcoholic liver disease：pathogenesis and new therapeutic targets. Gastroenterology,2011,141（5）：1572-1585.
[4] Ramstedt M. Alcohol and suicide in 14 European countries. Addiction,2001,96（Suppl 1）：S59-S75.
[5] Corrao GV,Bagnardi A,Zambon A,et al. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med,2004,38（5）：613-619.
[6] Kechagias S,Zanjani S,Gjellan S,et al. Effects of moderate red wine consumption on liver fat and blood lipids：a prospective randomized study. Ann Med,2011,43（7）：545-554.
[7] Zhou JY,Jiang ZA,Zhao CY,et al. Long-term binge and escalating ethanol exposure causes necroinflammation and fibrosis in rat liver. Alcohol Clin Exp Res,2013,37（2）：213-222.
[8] Shearn CT,Smathers RL,Jiang H,et al. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis. J Nutr Biochem,2013,24（8）：1436-1445.
[9] Seth D,Haber PS,Syn WK,et al. Pathogenesis of alcohol-induced liver disease：classical concepts and recent advances. J Gastroenterol Hepatol,2011,26（7）：1089-1105.
[10] Stickel F,Hampe J. Genetic determinants of alcoholic liver disease. Gut,2012,61（1）：150-159.
[11] Xu JK,Lai K,Verlinsky A,et al. Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. J Hepatol,2011,55（3）：673-682.
[12] Szabo G,Wands JR,Eken A,et al. Alcohol and hepatitis C virus—interactions in immune dysfunctions and liver damage. Alcohol Clin Exp Res,2010,34（10）：1675-1686.
[13] Mello T,Ceni E,Surrenti C,et al. Alcohol induced hepatic fibrosis：role of acetaldehyde. Mol Aspects Med,2008,29（1-2）：17-21.
[14] Kendrick SF,O'Boyle G,Mann J,et al. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis. Hepatology,2010,51（6）：1988-1997.
[15] Cruz A,Muntane J. Alcoholic liver disease,oxidative stress, and antioxidants. Rev Esp Enferm Dig,2011,103（8）：393-395.
[16] Harrison-Findik DD,Schafer D,Klein E,et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem,2006,281（32）：22974-22982.
[17] Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med,2008,29（1-2）：9-16.
[18] Sozio MD,Crabb W. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab,2008,295（1）：E10-16.
[19] Bardag-Gorce F,French BA,Nan L,et al. CYP2E1 induced by ethanol causes oxidative stress,proteasome inhibition and cytokeratin aggresome（Mallory body-like） formation. Exp Mol Pathol,2006,81（3）：191-201.
[20] Thakur V,Pritchard MT,McMullen MR,et al. Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells：role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol,2006,79（6）：1348-1356.
[21] Nieto N. Ethanol and fish oil induce NFkappaB transactivation of the collagen alpha2（I） promoter through lipid peroxidation-driven activation of the PKC-PI3K-Akt pathway. Hepatology,2007,45（6）：1433-1445.
[22] Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology,2009,50（2）：638-644.
[23] 李鑫,王晨,聂娇,等. 酒精性肝炎小鼠肝肠组织变化与内毒素血症的关系探讨. 实用肝脏病杂志,2013,16（3）：254-256.
[24] Rao RK,Seth KA,Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol,2004,286（6）：G881-G884.
[25] Mutlu E,Keshavarzian A,Engen P,et al. Intestinal dysbiosis： a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res,2009,33（10）：1836-1846.
[26] Forsyth CB,Farhadi A,Jakate SM,et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress,gut leakiness,and liver injury in a rat model of alcoholic steatohepatitis. Alcohol,2009,43（2）：163-172.
[27] Kirpich IA,Solovieva NV,Leikhter SN,et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury：a pilot study. Alcohol,2008,42（8）：675-682.
[28] Elamin E,Jonkers D,Juuti-Uusitalo K,et al. Effects of ethanol and acetaldehyde on tight junction integrity：in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One,2012,7（4）：e35008.
[29] Li X,Wang C,Nie J,et al. Toll-like receptor 4 increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis. Alcohol,2013,47（6）：459-465.
[30] Tang Y,Forsyth CB,Farhadi A,et al. Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res,2009,33（7）：1220-1230.
[31] Tang Y,Banan A,Forsyth CB,et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res,2008,32（2）：355-364.
[32] Szabo G,Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol,2010,16（11）：1321-1329.
[33] Zhong W,McClain CJ,Cave M,et al. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol,2010,298（5）：G625-G633.
[34] Voican CS,Perlemuter G,Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis：2011 update. Clin Res Hepatol Gastroenterol,2011,35（6-7）：465-474.
[35] Ohtake T,Saito H,Hosoki Y,et al. Hepcidin is down-regulated in alcohol loading. Alcohol Clin Exp Res,2007,31（1 Suppl）：S2-S8.
[36] Endo M,Masaki T,Seike M,et al. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c （SREBP-1c）. Exp Biol Med （Maywood）,2007,232（5）：614-621.
[37] Kang L,Sebastian BM,Pritchard MT,et al. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res,2007,31（9）：1581-1588.
[38] Jeong WI,Park O,Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology,2008,134（1）：248-258.
[39] Roychowdhury S,McMullen MR,Pritchard MT,et al. An early complement-dependent and TLR-4-independent phase in the pathogenesis of ethanol-induced liver injury in mice. Hepatology,2009,49（4）：1326-1334.
[40] Cohen JI,Roychowdhury S,McMullen MR,et al. Complement and alcoholic liver disease：role of C1q in the pathogenesis of ethanol-induced liver injury in mice. Gastroenterology,2010,139（2）：664-674.
[41] Lemmers A,Moreno C,Gustot T,et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology,2009,49（2）：646-657.
[42] Albano E,Vidali M. Immune mechanisms in alcoholic liver disease. Genes Nutr,2010,5（2）：141-147.
[43] Lian M,Hua J,Sheng L,et al. Prevalence and significance of autoantibodies in patients with alcoholic liver disease. J Dig Dis,2013,14（7）：396-401.
[44] Morales-Ibanez O,Dominguez M,Ki SH,et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology,2013,58（5）：1742-1756.
[45] You M,Rogers CQ. Adiponectin：a key adipokine in alcoholic fatty liver. Exp Biol Med（Maywood）,2009,234（8）：850-859.

Progress in the pathogenesis of alcoholic liver disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[3]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[4]	Qiu Jun, Wang Xueqing, Zhang Bo, et al. Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.
[5]	Yan Xisheng, Li Wei, Wang Jian, et al. Changes of serum cytokines and intestinal flora distribution in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 518-521.
[6]	Zhang Wei, Shi Junmei, Wang Qian. Fisk factors for occurrence of hyperbilirubinemia in neonates [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 534-536.
[7]	Li Fang, Zou Guizhou, Ye Jun, et al. Clinical features and risk factors of patients with decompensated cirrhosis and sepsis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 557-560.
[8]	Du Min, Zhou Min, Ji Zongshu. Clinical features and risk factors of liver injuries in patients with sepsis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 369-372.
[9]	Wang Haifang, Yang Dawei, Jia Bei. Impact of nutrition support and medusa administration on liver function, erythrocyte and platelet parameters in patients with alcoholic liver diseases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 381-384.
[10]	Liu Wenbo, Zhang Jianye, Bao Jiwu. Analysis of risk factors for stone recurrence in patients with common bile duct stones after ERCP and EST therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 437-440.
[11]	Wu Yaping, Zhou Bingqing, Jiang Peili. Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 196-199.
[12]	Wang Junyan, Chen Jianting, Zhang Ting, et al.. Risk factors of nosocomial infections in patients with hepatitis B liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 101-104.
[13]	Hu Hulan, Zhu Mengfei, Shi Junping.. Non-alcoholic fatty liver disease with concurrent chronic hepatitis B: What’s the progress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 149-152.
[14]	Guo Baona, Zhan Yutao.. Clinical features of alcoholic liver diseases:An analysis of 79 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 877-880.
[15]	Cui Ruibing, Yan Ming.. Etiology of ascites:what’s going on [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 657-660.